pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2011-0-4-49-53pulmo-358Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL STUDIESТрофименкоИ. Н.TrofimenkoI. N.

к. м. н., ассистент кафедры аллергологии и пульмонологии 

664079, Иркутск, м / р Юбилейный, 100. Тел.: 8-914-877-80-96.

tin11@mail.ruЧернякБ. А.ChernyakB. A.

д. м. н., проф., зав. кафедрой аллергологии и пульмонологии 

664079, Иркутск, м / р Юбилейный, 100. Тел.: 8-902-568-78-70.

bores@angara.ruГОУ ДПО "Иркутский государственный институт усовершенствования врачей"Russian Federation201128082011044953Copyright © Трофименко И.Н., Черняк Б.А., 20112011Трофименко И.Н., Черняк Б.А.Trofimenko I.N., Chernyak B.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/358ReferencesGlobal Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2009. www.goldcopd.comGlobal Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2009. www.goldcopd.comAgusti А., Calverley P.M.A., Celli B. et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11 (1): 122. http://respiratory)research.com/content/11/1/122Agusti А., Calverley P.M.A., Celli B. et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11 (1): 122. http://respiratory)research.com/content/11/1/122Трофименко И.Н., Черняк Б.А. Взаимосвязь клинико-функционального статуса и качества жизни у больных хронической обструктивной болезнью легких. Сиб. консилиум 2008; 1 (64): 48–52.Трофименко И.Н., Черняк Б.А. Взаимосвязь клинико-функционального статуса и качества жизни у больных хронической обструктивной болезнью легких. Сиб. консилиум 2008; 1 (64): 48–52.Nishimura K., Izumi T., Tsukino M. et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434–1440.Nishimura K., Izumi T., Tsukino M. et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434–1440.Gerardi D.A., Lovett L., Benoit)Connors M.L. et al. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur. Respir. J. 1996; 9: 431–435.Gerardi D.A., Lovett L., Benoit)Connors M.L. et al. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur. Respir. J. 1996; 9: 431–435.Oga T., Nishimura K., Tsukino M. et al. Analysis of the Factors related to mortality in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003; 167: 544–549.Oga T., Nishimura K., Tsukino M. et al. Analysis of the Factors related to mortality in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003; 167: 544–549.Casanova C., Cote C., de Torres J.P. et al. The inspiratory to total lung capacity ratio predicts mortality in patients with COPD. Am. J. Respir. Crit. Care Med. 2005; 171: 591–597.Casanova C., Cote C., de Torres J.P. et al. The inspiratory to total lung capacity ratio predicts mortality in patients with COPD. Am. J. Respir. Crit. Care Med. 2005; 171: 591–597.Hospers J.J., Postma D.S., Rijcken B. et al. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000; 356: 1313–1317.Hospers J.J., Postma D.S., Rijcken B. et al. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000; 356: 1313–1317.Schols A.M., Slangen J., Volovics L., Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 1791–1797.Schols A.M., Slangen J., Volovics L., Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 1791–1797.Agust A., Noguera A., Sauleda J. et al. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 21: 347–360.Agust A., Noguera A., Sauleda J. et al. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 21: 347–360.Wouters E.F. COPD: from an organ- to a disease-oriented approach. COPD 2008; 5 (2): 73–74.Wouters E.F. COPD: from an organ- to a disease-oriented approach. COPD 2008; 5 (2): 73–74.Agusti A. COPD, a multicomponent disease: implications for management. Respir. Med. 2005; 99: 670–682.Agusti A. COPD, a multicomponent disease: implications for management. Respir. Med. 2005; 99: 670–682.Burgel P. R., Paillasseur J.L., Caillaud D. et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur. Respir. J. 2010; 36: 531–539.Burgel P. R., Paillasseur J.L., Caillaud D. et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur. Respir. J. 2010; 36: 531–539.Han M.K., Agusti A., Calverley P.M. et al. COPD phenotypes: The future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182: 598–604.Han M.K., Agusti A., Calverley P.M. et al. COPD phenotypes: The future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182: 598–604.Авдеев С.Н. Фенотипы хронической обструктивной болезни легких: особенности терапии. Consilium medicum 2010; прилож.: 23–28.Авдеев С.Н. Фенотипы хронической обструктивной болезни легких: особенности терапии. Consilium medicum 2010; прилож.: 23–28.Garsia)Aymerich J., Agusti A., Barbera J.A. et al. Phenotypic heterogenetiy of chronic obstructive pulmonary disease. Arch. Broncopneumol. 2009; 45: 133–142.Garsia)Aymerich J., Agusti A., Barbera J.A. et al. Phenotypic heterogenetiy of chronic obstructive pulmonary disease. Arch. Broncopneumol. 2009; 45: 133–142.Gulsvik A., Refvem O.K. Ascoring system on respiratory symptoms. Eur. Respir. J. 1988; 1: 428–432.Gulsvik A., Refvem O.K. Ascoring system on respiratory symptoms. Eur. Respir. J. 1988; 1: 428–432.Чучалин А.Г. (ред.). Стандартизация легочных функциональных тестов. Пер. с англ. М.; 1993.Чучалин А.Г. (ред.). Стандартизация легочных функциональных тестов. Пер. с англ. М.; 1993.Kanner R.E., Connett J.E., Altose M.D. et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am. J. Respir. Crit. Care Med. 1994; 150 (4): 956–961.Kanner R.E., Connett J.E., Altose M.D. et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am. J. Respir. Crit. Care Med. 1994; 150 (4): 956–961.Brutsche M.H., Downs S.H., Schindler C. et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax 2006; 61: 671–677.Brutsche M.H., Downs S.H., Schindler C. et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax 2006; 61: 671–677.Grootendorst D.C., Rabe K.F. Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2004; 1: 77–87.Grootendorst D.C., Rabe K.F. Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2004; 1: 77–87.Khaodhiar L., Ling P.R., Blackburn G.L. et al. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. J. Parenter. Enter. Nutr. 2004; 28 (6): 410–415.Khaodhiar L., Ling P.R., Blackburn G.L. et al. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. J. Parenter. Enter. Nutr. 2004; 28 (6): 410–415.Bahceci M., Gokalp D., Bahceci S. et al. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J. Endocrinol. Invest. 2007; 30 (3): 210–214.Bahceci M., Gokalp D., Bahceci S. et al. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J. Endocrinol. Invest. 2007; 30 (3): 210–214.Xu X., Rijcken B., Schouten J.P. et al. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350: 1431–1434.Xu X., Rijcken B., Schouten J.P. et al. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350: 1431–1434.Leuppi J.D., Tandjung R., Anderson S.D. et al. Prediction of treatment-response to inhaled corticosteroids by mannitolchallenge test in COPD. A proof of concept. Pulm. Pharmacol. Ther. 2005; 18 (2): 83–88.Leuppi J.D., Tandjung R., Anderson S.D. et al. Prediction of treatment-response to inhaled corticosteroids by mannitolchallenge test in COPD. A proof of concept. Pulm. Pharmacol. Ther. 2005; 18 (2): 83–88.

The authors declare that there are no conflicts of interest present.